GLOBALHealthPR

by

Today’s blog comes to us from Jonathan Wilson, President of GLOBALHealthPR US Partner and Chair, Spectrum.

The United States Food and Drug Administration (FDA) is rethinking its rules on what kind of information pharma companies can share with physicians regarding off-label use of their products. That’s good news for the practice of medicine.

At the moment, pharma company employees can talk about a drug only in the context of the condition indicated in its FDA-approved label. Anything they say about another, unapproved use of the drug is considered “misbranding” according to federal law, and subjects the company to civil and criminal prosecution. [Read more…] about Scientific Exchange Calls for Some Talk of “Off-Label” Use

by

Prime-Minister-John-Curtin-in-London1_7815338_tcm11-18299
Prime Minister John Curtin, who devised the first PBS in Australia during World War II.

Today’s post comes to us from Mark Henderson of GLOBALHealthPR Australia Partner, VIVA! Communications.

The Pharmaceutical Benefits Scheme, or PBS, is a programme administered by the Australian Government to provide patients with heavily subsidised access to a broad range of prescription medicines. Despite its expansion over the years, access to treatments for some rare disorders under the PBS remains elusive today. [Read more…] about Unravelling Australia’s Pharmaceutical Benefits Scheme

by

In today’s post, Paola de la Barreda of our GLOBALHealthPR Mexico partner, PRP, explains how rebranding is much more than just a tale of two logos.prpnuevo

When we founded PRP, we were two young women, not particularly well-known, launching a company in an industry of well-established multinational and local competitors.

With this in mind, our logo—the core of our identity—was serious and formal, designed to communicate our professionalism and capability to represent big brands. The logo also included the words “PR Partners” below PRP, because at the time we felt the need to explain what we did.

Fourteen years later, PRP has had the honor of handling prestigious brands and multinational companies, from healthcare to consumer industries. [Read more…] about Ready to Rebrand? Here’s What You Need to Know

by

Today’s post comes to us from our GLOBALHealthPR Argentina partner, Paradigma PEL Comunicación.

In Argentina, fluff science pieces, parental perceptions of the “natural way” to raise children and a general weariness of industry and government have led to a rise in anti-vaccine movements. It’s time to take the science seriously and start discussing the facts, scientific communicators say.Child receiving vaccine

At a time when anti-vaccine movements are growing and their dangerous consequences have started to attract attention throughout the world, Argentine mass media have not been alien to the immunization debate. At times they have had a positive impact, while at others, not so much. [Read more…] about The Risk of Misinforming when Talking about Vaccination

by

odwyercoverWhen it comes to international public relations, the right collaboration can change lives. That’s the word from GLOBALHealthPR Chair, John Seng, who was featured in this month’s global issue of O’Dwyer’s, the United States’ leading publication for PR and marketing communications professionals.

Seng’s article highlights the value of a healthcare-only network of independent communications agencies and how this model provides the reach and local insights to impact patients’ lives through innovative campaigns. [Read more…] about Why Global PR Matters

by

Today’s featured post comes to us from our GLOBALHealthPR Spain partner, Berbés Asociados.

Last Monday, in the wake of elections to the European Parliament and with no prior warning, the media was caught off-guard by an announcement by Spain’s Prime Minister Mariano Rajoy to call a press conference. The reason was to inform of changes to the country’s monarchy. The media were unanimous: King Juan Carlos’s abdication was a virtual certainty. Now it is a reality. [Read more…] about The Next Generation